Anticholinergic anti-Parkinson medication for neuroleptic-induced extrapyramidal side effects.
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D006801:Humans; D009966:Orphenadrine / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D009966:Orphenadrine